Ryland re big pharm....
Thanks for your insights. In re to point c:
Do you think we are getting very close to the point that big pharm just can't fight the tape anymore? Point being, do you feel public perception and support has shifted pro enough, that when it comes to medicinal, they just can't stop it legislatively? They floated what I think was not that well supported of a med bill in conservative leaning fl last election and it got 58% approval just missing 60. Don't you think with so many ballots going thru in '16, that the scale has tipped?
Secondly, if big pharm does indeed concede trying to fight the wave, do you think they will quickly upramp into the industry themselves?
If so, do you think they will go in house with diagnostic testing, outsource it to experts like steephill or look to merge and acquire companies with the expertise? It seems like in house would be difficult because companies like Pfizer are mainly dealing with chemical compounds in the lab, not the actual agric plant itself like with mj. It would seem the intellectual capital catchup time plus equipt costs wouldn't be worth it.
News 
Market Data 
Discover 
